MEDTRONIC NEUROMODULATION
Manufacturer adverse-event records for MEDTRONIC NEUROMODULATION come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.
FDA MAUDE device safety record · 2004–2026 · heavy-book · elevated Death-code · injury-heavy
Volume signature
MEDTRONIC NEUROMODULATION sits in the heavy MAUDE book
MEDTRONIC NEUROMODULATION accounts for 57,580 FDA MAUDE reports (#60 of 443, heavy-book tercile). Death-coded event_type share is 1.33% (elevated); Injury share 55.2% (injury-heavy).
What the volume reading shows for MEDTRONIC NEUROMODULATION
The standout signal for MEDTRONIC NEUROMODULATION is filing volume: 57,580 adverse-event reports in FDA MAUDE (#60 of 443, heavy-book). Death-coded event_type share sits at 1.33% (elevated).
As a heavy-book manufacturer, portfolio size and reporting obligations inflate absolute counts - pair MEDTRONIC NEUROMODULATION with device-family pages before treating company totals as a safety verdict. Event_type Death and Injury are one code per report; Patient Outcomes below use a separate FDA population.
Reports span 20 device types, led in this extract by Injury at 31,776 (55.2% of event_type total). Peak single-year volume reaches 4,836 reports across 23 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.
Event Types
Patient Outcomes
FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.
Devices (20)
Yearly Trend
Read our methodology - how this data is sourced, computed, and verified.